Patents by Inventor Horst Baganz

Horst Baganz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Blood pressure lowering in human mammals
    Patent number: 4025639
    Abstract: 2-[.alpha.-(2,6-Dichlorophenoxy)-ethyl]-.DELTA..sup.2 -imidazoline, and physiologically acceptable acid addition salts thereof, which provide vasoactivity and hypotensive activity.
    Type: Grant
    Filed: December 5, 1975
    Date of Patent: May 24, 1977
    Assignee: A. Nattermann & Cie GmbH
    Inventors: Horst Baganz, Hans-Joachim May
  • Imidazoline derivatives and processes for the production thereof
    Patent number: 3966757
    Abstract: 2-[.alpha.-(2,6-DICHLOROPHENOXY)-ETHYL]-.DELTA..sup.2 -IMIDAZOLINE, AND PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF, WHICH PROVIDE VASOACTIVITY AND HYPOTENSIVE ACTIVITY.
    Type: Grant
    Filed: April 8, 1975
    Date of Patent: June 29, 1976
    Assignee: A. Nattermann & Cie GmbH
    Inventors: Horst Baganz, Hans-Joachim May